MRVI Maravai LifeSciences Holdings

Maravai LifeSciences To Host Earnings Conference Call on Monday, May 12, 2025

Maravai LifeSciences To Host Earnings Conference Call on Monday, May 12, 2025

SAN DIEGO, May 01, 2025 (GLOBE NEWSWIRE) -- (Maravai) (NASDAQ: MRVI), a global provider of life science reagents and services to researchers and biotech innovators, plans to announce its first quarter 2025 financial and operating results after the market close on Monday, May 12, 2025, and will host a conference call and webcast on the same day at 2:00 p.m. PT/ 5:00 p.m. ET.

To participate in the conference call by telephone, dial (800) 343-4849 or (203) 518-9848 and reference Maravai LifeSciences, Conference ID MARAVAI. The call will also be available via live or archived webcast on the "Investors" section of the Maravai web site at .

About Maravai

Maravai is a leading life sciences company providing critical products to enable the development of drug therapies, diagnostics, and novel vaccines and to support research on human diseases. Maravai’s companies are leaders in providing products and services in the fields of nucleic acid synthesis and biologics safety testing to many of the world's leading biopharmaceutical, vaccine, diagnostics, and cell and gene therapy companies.



Contact Information:
Deb Hart
Maravai LifeSciences
 7
EN
01/05/2025

Underlying

MRVIMaravai LifeSciences Holdings

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on Maravai LifeSciences Holdings

 PRESS RELEASE
Free
MRVI Maravai LifeSci...

Maravai LifeSciences To Host Earnings Conference Call on Monday, May 1...

Maravai LifeSciences To Host Earnings Conference Call on Monday, May 12, 2025 SAN DIEGO, May 01, 2025 (GLOBE NEWSWIRE) -- (Maravai) (NASDAQ: MRVI), a global provider of life science reagents and services to researchers and biotech innovators, plans to announce its first quarter 2025 financial and operating results after the market close on Monday, May 12, 2025, and will host a conference call and webcast on the same day at 2:00 p.m. PT/ 5:00 p.m. ET. To participate in the conference call by telephone, dial (800) 343-4849 or (203) 518-9848 and reference Maravai LifeSciences, Conference I...

4h / 20m 1 EN
 PRESS RELEASE
Free
MRVI Maravai LifeSci...

Maravai Lifesciences Reports Fourth Quarter and Full Year 2024 Financi...

Maravai Lifesciences Reports Fourth Quarter and Full Year 2024 Financial Results Schedules Conference Call for Thursday, March 20, 2025 SAN DIEGO, March 18, 2025 (GLOBE NEWSWIRE) -- Maravai LifeSciences Holdings, Inc. (Maravai) (NASDAQ: MRVI), a global provider of life science reagents and services to researchers and biotech innovators, today reported financial results for the fourth quarter and full year ended December 31, 2024, together with other business updates. The company also expects to file its Annual Report on Form 10-K for the year ended December 31, 2024, with the Securities...

March 18, 2025 1 EN
 PRESS RELEASE
Free
MRVI Maravai LifeSci...

Maravai LifeSciences Postpones its Fourth Quarter and Full Year 2024 E...

Maravai LifeSciences Postpones its Fourth Quarter and Full Year 2024 Earnings Release and Conference Call SAN DIEGO, Feb. 25, 2025 (GLOBE NEWSWIRE) -- Maravai LifeSciences Holdings, Inc. (Maravai) (NASDAQ: MRVI), a global provider of life science reagents and services to researchers and biotech innovators, today announced that it is postponing its previously announced earnings release and call scheduled for February 25, 2025. It also announced that it intends to file a Form 12b-25, Notification of Late Filing, with the U.S. Securities and Exchange Commission and will delay the filing its ...

February 25, 2025 1 EN
 PRESS RELEASE
Free
MRVI Maravai LifeSci...

Maravai LifeSciences Announces Preliminary Unaudited 2024 Revenue

Maravai LifeSciences Announces Preliminary Unaudited 2024 Revenue Announces Earnings Release Date SAN DIEGO, Jan. 08, 2025 (GLOBE NEWSWIRE) --  (Maravai) (NASDAQ: MRVI), a global provider of life science reagents and services to researchers and biotech innovators, today announced that based on preliminary year-end results and subject to year-end closing adjustments, the Company expects to report total 2024 revenue near the mid-point of the previously announced guidance range of $255.0 million and $265.0 million. The Company also announced that it plans to announce its fourth quarter a...

January 8, 2025 1 EN
 PRESS RELEASE
Free
MRVI Maravai LifeSci...

Maravai LifeSciences Appoints R. Andrew Eckert as Chairman of the Boar...

Maravai LifeSciences Appoints R. Andrew Eckert as Chairman of the Board of Directors Carl Hull to Retire as Executive Chairman SAN DIEGO, Dec. 05, 2024 (GLOBE NEWSWIRE) -- (“Maravai” or the “Company”) (NASDAQ: MRVI), a global provider of life science reagents and services to researchers and biotech innovators, announced that Carl Hull will retire from his position as Executive Chairman of the Board and that the Board of Directors has unanimously elected R. Andrew Eckert to succeed him as Chairman of the Board, effective December 5, 2024. Carl Hull founded Maravai in 2014 and served as...

December 5, 2024 1 EN

ResearchPool Subscriptions

Get the most out of your insights

Get in touch